Shahid Kaleem Siddiqui, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Siddiqui’s office at (408) 770-3102 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$468,771
Medicare paid this office $468,771 for 514 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 94 | $150,013 | $1,579 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 94 | $77,843 | $410 |
| Return visit (30+ min) | 260 | $62,726 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 163 | $34,555 | $202 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 51 | $24,411 | $469 |
See all 23 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 94 | $150,013 | $1,579 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 94 | $77,843 | $410 |
| Return visit (30+ min) | 260 | $62,726 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 163 | $34,555 | $202 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 51 | $24,411 | $469 |
| Critical care, first 30-74 minutes | 32 | $13,771 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $13,687 | $106 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 149 | $10,678 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $10,077 | $155 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $9,269 | $61 |
| New patient visit (45+ min) | 61 | $8,563 | $140 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 51 | $7,926 | $76 |
| Injection of drug or substance into vein | 144 | $5,715 | $39 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $5,210 | $124 |
| Programming of dual lead pacemaker system | 43 | $4,856 | $69 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $3,914 | $206 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 43 | $3,071 | $70 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 81 | $1,382 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 86 | $1,097 | $12 |
| Injection, regadenoson, 0.1 mg | 30 | $656 | None |
| Infusion, normal saline solution, 250 cc | 139 | $584 | None |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 16 | $364 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 16 | $211 | $13 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 35 | More than 70% of doctors who do this |
| Pacemaker insertion or repair | 34 | More than 81% of doctors who do this |
Who their Medicare patients are
514 Original Medicare patients in 2024. Average age 78 · Under 65 6% · 85 and older 26% · Women 48% · Also on Medicaid 60% · Health risk score 1.96. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 63% · Diabetes 62% · Chronic kidney disease 39% · Atrial fibrillation 39% · Heart failure 35% · Depression 23% · Stroke 21% · Dementia 20% · COPD 19% · Cancer 14%.
The office billed $1,135,170, Medicare allowed $598,124 and paid $468,771; for 7,161 services of 44 kinds; $2,622 of it was for drugs given in the office and $466,149 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 514 | 7,161 | 78 | 1.96 | $1,135,170 | $468,771 |
| 2023 | 515 | 10,151 | 78 | 1.85 | $1,425,443 | $598,200 |
| 2022 | 497 | 8,740 | 77 | 2.00 | $1,123,549 | $494,805 |
| 2021 | 613 | 13,240 | 77 | 2.06 | $1,595,815 | $722,265 |
| 2020 | 503 | 8,977 | 77 | 2.14 | $1,061,527 | $479,577 |
| 2019 | 623 | 16,712 | 76 | 1.94 | $1,652,062 | $709,518 |
| 2018 | 634 | 16,501 | 75 | 2.11 | $1,706,621 | $804,081 |
| 2017 | 694 | 14,841 | 76 | 2.00 | $1,763,795 | $788,194 |
| 2016 | 592 | 14,586 | 76 | 1.83 | $1,523,146 | $592,100 |
| 2015 | 638 | 10,158 | 76 | 1.86 | $1,231,305 | $471,017 |
| 2014 | 785 | 11,415 | 76 | 1.69 | $1,645,944 | $576,501 |
| 2013 | 859 | 7,314 | 76 | 1.81 | $2,188,416 | $634,462 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 134 | $215,262 | $1,571 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 135 | $112,569 | $408 |
| Return visit (30+ min) | 272 | $60,918 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | $41,153 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $21,116 | $107 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $17,481 | $472 |
| Critical care, first 30-74 minutes | 26 | $17,291 | $188 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $12,886 | $403 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 173 | $12,194 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $11,416 | $152 |
| New patient visit (45+ min) | 66 | $9,886 | $150 |
| Telephone medical discussion with physician, 21-30 minutes | 72 | $8,731 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 133 | $8,324 | $62 |
| Injection of drug or substance into vein | 169 | $6,799 | $40 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 37 | $5,640 | $76 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $5,426 | $175 |
| Programming of dual lead pacemaker system | 47 | $5,137 | $69 |
| Injection, regadenoson, 0.1 mg | 18 | $3,163 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,458 | $70 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 134 | $2,441 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 112 | $1,545 | $13 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 45 | $1,051 | $23 |
| Infusion, normal saline solution, 250 cc | 171 | $705 | None |
| Heart rhythm recording of continous external ekg over 8-15 days | 45 | $575 | $12 |
2022: 26 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 100 | $160,077 | $1,601 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 100 | $83,037 | $415 |
| Return visit (30+ min) | 272 | $65,995 | $116 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $29,624 | $203 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 47 | $23,345 | $497 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $14,855 | $93 |
| Telephone medical discussion with physician, 21-30 minutes | 108 | $14,306 | $113 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 148 | $10,210 | $69 |
| Critical care, first 30-74 minutes | 19 | $10,155 | $195 |
| New patient visit (45+ min) | 71 | $10,080 | $142 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $9,644 | $419 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 47 | $8,226 | $88 |
| Programming of dual lead pacemaker system | 52 | $7,692 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,388 | $180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 103 | $6,832 | $64 |
| Injection of drug or substance into vein | 145 | $6,187 | $42 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $5,004 | $192 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 120 | $1,911 | None |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 54 | $1,518 | $24 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,368 | $65 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 17 | $1,074 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 79 | $1,060 | $13 |
| Heart rhythm recording of continous external ekg over 8-15 days | 54 | $940 | $15 |
| Infusion, normal saline solution, 250 cc | 143 | $610 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $260 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $161 | $13 |
2021: 29 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 164 | $271,182 | $1,644 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 164 | $139,087 | $421 |
| Return visit (30+ min) | 281 | $59,445 | $120 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 211 | $46,186 | $217 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 42 | $22,116 | $527 |
| Telephone medical discussion with physician, 21-30 minutes | 156 | $20,742 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $20,191 | $94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 207 | $14,778 | $71 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $13,382 | $406 |
| New patient visit (45+ min) | 87 | $12,780 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 175 | $11,822 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $11,720 | $180 |
| Injection of drug or substance into vein | 206 | $9,286 | $45 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 42 | $7,553 | $90 |
| Critical care, first 30-74 minutes | 14 | $6,984 | $200 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $6,800 | $212 |
| Insertion of permanent leadless pacemaker using imaging guidance | 15 | $6,674 | $445 |
| Programming of dual lead pacemaker system | 40 | $6,672 | $75 |
| Telephone medical discussion with physician, 11-20 minutes | 56 | $5,174 | $85 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 52 | $4,157 | $78 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 192 | $3,900 | None |
| Long return visit (40+ min) | 17 | $2,416 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 112 | $1,642 | $15 |
| Infusion, normal saline solution, 250 cc | 204 | $907 | None |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 31 | $815 | $25 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $799 | $73 |
| Heart rhythm recording of continous external ekg over 8-15 days | 31 | $516 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $347 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $233 | $14 |
2020: 29 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 113 | $188,391 | $1,667 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 113 | $95,022 | $420 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 145 | $31,165 | $211 |
| Return visit (30+ min) | 225 | $29,231 | $90 |
| Telephone medical discussion with physician, 21-30 minutes | 148 | $17,253 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $15,258 | $97 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 20 | $10,386 | $519 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 133 | $9,678 | $71 |
| New patient visit (45+ min) | 67 | $9,450 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,721 | $188 |
| Critical care, first 30-74 minutes | 11 | $7,672 | $202 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $7,116 | $474 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 85 | $6,010 | $69 |
| Injection of drug or substance into vein | 131 | $5,620 | $42 |
| Telephone medical discussion with physician, 11-20 minutes | 60 | $4,138 | $63 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 20 | $3,593 | $90 |
| Short return visit (20+ min) | 58 | $3,229 | $53 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,203 | $200 |
| Programming of dual lead pacemaker system | 37 | $3,148 | $59 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 126 | $2,771 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $1,995 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 83 | $1,440 | $17 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,308 | $77 |
| External ekg recording for more than 48 hours up to 21 days | 20 | $624 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 20 | $550 | $25 |
| Infusion, normal saline solution, 250 cc | 131 | $538 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 12 | $458 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $335 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $225 | $14 |
2019: 26 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 155 | $242,894 | $1,567 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 156 | $129,773 | $416 |
| Return visit (30+ min) | 416 | $86,194 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 229 | $48,135 | $206 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 62 | $31,600 | $510 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $23,867 | $95 |
| Critical care, first 30-74 minutes | 20 | $15,360 | $197 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 218 | $15,269 | $69 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $14,400 | $411 |
| New patient visit (45+ min) | 96 | $13,347 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $11,909 | $180 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 62 | $11,004 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 134 | $9,137 | $67 |
| Injection of drug or substance into vein | 213 | $8,796 | $41 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 191 | $6,544 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 73 | $6,286 | $84 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $6,160 | $199 |
| Programming of dual lead pacemaker system | 45 | $4,721 | $59 |
| Long return visit (40+ min) | 25 | $3,340 | $134 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 125 | $2,121 | $17 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $1,095 | $68 |
| Infusion, normal saline solution, 250 cc | 212 | $831 | None |
| External ekg recording for more than 48 hours up to 21 days | 17 | $451 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 17 | $394 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $328 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $220 | $13 |
2018: 26 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 165 | $287,953 | $1,745 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 165 | $134,817 | $409 |
| Return visit (30+ min) | 416 | $98,970 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $59,159 | $232 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 49 | $28,344 | $578 |
| Critical care, first 30-74 minutes | 30 | $21,974 | $222 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 101 | $21,736 | $106 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 218 | $16,932 | $77 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $16,332 | $495 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $15,461 | $201 |
| New patient visit (45+ min) | 89 | $13,874 | $156 |
| Injection of drug or substance into vein | 212 | $11,558 | $55 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 49 | $9,667 | $99 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 98 | $9,569 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $9,436 | $75 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $8,735 | $218 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 192 | $6,956 | None |
| Programming of dual lead pacemaker system | 52 | $5,370 | $58 |
| Long return visit (40+ min) | 20 | $3,020 | $151 |
| Short return visit (20+ min) | 35 | $2,908 | $79 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,371 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 108 | $2,010 | $18 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $893 | $81 |
| Infusion, normal saline solution, 250 cc | 211 | $617 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 24 | $546 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 24 | $366 | $15 |
2017: 26 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 163 | $277,570 | $1,703 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 164 | $87,724 | $267 |
| Return visit (30+ min) | 374 | $82,182 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 247 | $66,536 | $265 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 116 | $30,550 | $108 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $29,147 | $583 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 39 | $29,084 | $485 |
| Critical care, first 30-74 minutes | 38 | $24,250 | $227 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $18,978 | $206 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 221 | $18,667 | $84 |
| New patient visit (45+ min) | 112 | $16,857 | $151 |
| Injection of drug or substance into vein | 212 | $14,554 | $68 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 55 | $12,323 | $220 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 157 | $11,274 | $67 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 50 | $10,058 | $101 |
| Short return visit (20+ min) | 119 | $9,567 | $75 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 94 | $9,364 | $96 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 179 | $4,961 | None |
| Programming of dual lead pacemaker system | 49 | $4,287 | $54 |
| Long return visit (40+ min) | 22 | $3,282 | $149 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,428 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 125 | $2,343 | $19 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 13 | $1,073 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $672 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $451 | $16 |
| Infusion, normal saline solution, 250 cc | 212 | $167 | None |
2016: 23 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 120 | $173,365 | $1,433 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 264 | $61,947 | $229 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 119 | $59,701 | $502 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 120 | $55,935 | $231 |
| Return visit (30+ min) | 264 | $34,109 | $90 |
| Short return visit (20+ min) | 289 | $29,577 | $66 |
| Critical care, first 30-74 minutes | 29 | $21,525 | $196 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 119 | $20,732 | $87 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 238 | $16,934 | $70 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $14,477 | $439 |
| Injection of drug or substance into vein | 235 | $13,954 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $12,832 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,632 | $174 |
| New patient visit (45+ min) | 71 | $10,017 | $141 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 89 | $7,925 | $83 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $6,840 | $207 |
| New patient visit (60+ min) | 39 | $6,494 | $167 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 108 | $6,246 | $57 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 181 | $5,885 | None |
| Programming of dual lead pacemaker system | 48 | $3,636 | $47 |
| Long return visit (40+ min) | 20 | $2,252 | $113 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 130 | $2,125 | $16 |
| Infusion, normal saline solution, 250 cc | 235 | $381 | None |
2015: 28 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 160 | $80,168 | $498 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 44 | $63,332 | $1,439 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 227 | $51,805 | $224 |
| Return visit (30+ min) | 305 | $43,668 | $90 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 161 | $28,188 | $87 |
| New patient visit (60+ min) | 124 | $21,579 | $174 |
| Short return visit (20+ min) | 224 | $21,161 | $66 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 44 | $20,220 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $16,837 | $93 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 28 | $16,636 | $450 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $14,367 | $180 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 204 | $13,818 | $66 |
| Injection of drug or substance into vein | 201 | $11,984 | $58 |
| Critical care, first 30-74 minutes | 20 | $11,583 | $196 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 124 | $7,435 | $57 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $6,573 | $193 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 68 | $5,756 | $81 |
| Programming of dual lead pacemaker system | 63 | $5,266 | $48 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 107 | $3,796 | None |
| Long return visit (40+ min) | 22 | $2,630 | $120 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 159 | $2,628 | $16 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,048 | $71 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $1,326 | $17 |
| Blood test, clotting time | 13 | $514 | $5 |
| Infusion, normal saline solution, 250 cc | 170 | $389 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $381 | $20 |
| Insertion of needle into vein for collection of blood sample | 13 | $288 | $3 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $248 | $13 |
2014: 27 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 285 | $146,719 | $496 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 349 | $82,657 | $227 |
| Short return visit (20+ min) | 475 | $50,232 | $60 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 286 | $50,002 | $87 |
| Critical care, first 30-74 minutes | 41 | $25,411 | $195 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 37 | $23,510 | $444 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $21,904 | $92 |
| New patient visit (60+ min) | 125 | $21,649 | $173 |
| Return visit (30+ min) | 194 | $20,711 | $96 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 284 | $18,632 | $63 |
| Injection of drug or substance into vein | 285 | $16,853 | $57 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 154 | $13,500 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,192 | $176 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 143 | $11,688 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 152 | $9,013 | $57 |
| Programming of dual lead pacemaker system | 87 | $7,079 | $48 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $7,015 | $206 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 176 | $2,806 | $16 |
| Long return visit (40+ min) | 21 | $2,570 | $122 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $2,047 | $16 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 22 | $1,505 | $17 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $1,184 | $70 |
| Blood test, clotting time | 24 | $810 | $5 |
| Insertion of needle into vein for collection of blood sample | 24 | $450 | $3 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $437 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $286 | $13 |
| Infusion, normal saline solution, 250 cc | 283 | $76 | None |
2013: 31 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 325 | $166,123 | $510 |
| Short return visit (20+ min) | 566 | $75,296 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 379 | $72,032 | $185 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 184 | $47,844 | None |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 325 | $28,614 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $27,325 | $90 |
| Critical care, first 30-74 minutes | 33 | $24,546 | $190 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 325 | $22,314 | $17 |
| Injection of drug or substance into vein | 318 | $18,622 | $58 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 182 | $16,593 | $85 |
| New patient visit (60+ min) | 85 | $15,348 | $181 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $12,974 | $173 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $12,319 | $385 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 20 | $11,598 | $552 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 195 | $10,759 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 145 | $9,606 | $66 |
| Programming of dual lead pacemaker system | 102 | $7,783 | $45 |
| New patient visit (45+ min) | 49 | $6,583 | $134 |
| Return visit (30+ min) | 61 | $6,058 | $95 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $5,796 | $193 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 197 | $3,511 | $17 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $3,109 | $18 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $2,112 | $68 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,660 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,303 | $62 |
| Blood test, clotting time | 35 | $1,148 | $5 |
| Insertion of needle into vein for collection of blood sample | 35 | $638 | $3 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 32 | $615 | $19 |
| Programming of dual lead pacemaker system | 14 | $498 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 32 | $407 | $13 |
| Infusion, normal saline solution, 250 cc | 323 | $72 | None |
Medicaid work
$9,510 in 2024
Medicaid paid $9,510 for 433 billed services this clinician did in 2024, up to 37 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 205 | $8,136 |
| Return visit (30+ min) | 199 | $1,374 |
| TOBACCO NON-USER | 15 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 14 | $0 |
| 2024 | 433 | 4 | 37 | $9,510 |
| 2023 | 1,455 | 12 | 63 | $30,099 |
| 2022 | 897 | 10 | 53 | $12,866 |
| 2021 | 1,668 | 14 | 50 | $33,930 |
| 2020 | 569 | 9 | 32 | $13,606 |
| 2019 | 537 | 6 | 33 | $20,692 |
| 2018 | 605 | 7 | 43 | $33,103 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 392 | $16,861 |
| Return visit (30+ min) | 518 | $5,180 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 40 | $2,401 |
| CARDIOVASCULAR STRESS TEST | 163 | $2,259 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 38 | $1,465 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 176 | $1,186 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 16 | $535 |
| New patient visit (45+ min) | 51 | $116 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 12 | $86 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 12 | $10 |
| TOBACCO NON-USER | 18 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 19 | $0 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 200 | $6,757 |
| Return visit (30+ min) | 450 | $4,344 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 12 | $1,068 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 75 | $375 |
| CARDIOVASCULAR STRESS TEST | 17 | $302 |
| New patient visit (45+ min) | 36 | $21 |
| TOBACCO NON-USER | 42 | $0 |
| Patient screened for future fall risk; documentation of 2 or more falls in the past year or any fall with injury in the past year (GER) | 12 | $0 |
| FALLS RISK ASSESSMENT DOCUMENTED | 12 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 41 | $0 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 371 | $15,137 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 54 | $5,378 |
| Return visit (30+ min) | 445 | $4,921 |
| CARDIOVASCULAR STRESS TEST | 167 | $3,085 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 57 | $2,989 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 141 | $866 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 44 | $549 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 83 | $500 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 13 | $443 |
| New patient visit (45+ min) | 52 | $62 |
| TOBACCO NON-USER | 44 | $0 |
| Patient screened for future fall risk; documentation of 2 or more falls in the past year or any fall with injury in the past year (GER) | 55 | $0 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 152 | $9,412 |
| Return visit (30+ min) | 165 | $2,975 |
| CARDIOVASCULAR STRESS TEST | 40 | $706 |
| Short return visit (20+ min) | 70 | $214 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 17 | $180 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 25 | $119 |
| TOBACCO NON-USER | 45 | $0 |
| FALLS RISK ASSESSMENT DOCUMENTED | 41 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 14 | $0 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 159 | $13,448 |
| Return visit (30+ min) | 298 | $5,693 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 12 | $549 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 42 | $468 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 12 | $367 |
| CARDIOVASCULAR STRESS TEST | 14 | $167 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 164 | $18,991 |
| Return visit (30+ min) | 310 | $7,299 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 13 | $2,321 |
| CARDIOVASCULAR STRESS TEST | 39 | $1,692 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 12 | $1,281 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 53 | $886 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 14 | $633 |
Drugs they prescribed that Part D paid
$572,005
Pharmacies billed $572,005 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,043 generic and 433 brand-name prescriptions · $572,005 in drug cost · 15 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 253 | $357,639 | $1,414 |
| Xarelto | 51 | $76,267 | $1,495 |
| Entresto | 41 | $45,022 | $1,098 |
| Brilinta | 39 | $29,966 | $768 |
| Jardiance | 11 | $7,339 | $667 |
See all 32 drugs
| Eliquis | 253 | $357,639 | $1,414 |
| Xarelto | 51 | $76,267 | $1,495 |
| Entresto | 41 | $45,022 | $1,098 |
| Brilinta | 39 | $29,966 | $768 |
| Jardiance | 11 | $7,339 | $667 |
| Metoprolol | 270 | $5,376 | $20 |
| Atorvastatin | 282 | $3,223 | $11 |
| Ranolazine Er | 20 | $3,122 | $156 |
| Clopidogrel | 184 | $2,562 | $14 |
| Rosuvastatin | 91 | $1,894 | $21 |
| Losartan | 117 | $1,370 | $12 |
| Metoprolol | 125 | $1,163 | $9 |
| Amlodipine Besylate | 211 | $957 | $5 |
| Sotalol | 45 | $950 | $21 |
| Flecainide Acetate | 15 | $949 | $63 |
| Losartan-Hydrochlorothiazide | 58 | $783 | $14 |
| Carvedilol | 85 | $691 | $8 |
| Valsartan | 14 | $682 | $49 |
| Hydralazine | 30 | $528 | $18 |
| Digoxin | 12 | $486 | $40 |
| Omeprazole | 29 | $471 | $16 |
| Pantoprazole | 26 | $443 | $17 |
| Furosemide | 77 | $411 | $5 |
| Lisinopril | 38 | $368 | $10 |
| Olmesartan Medoxomil | 14 | $354 | $25 |
| Spironolactone | 45 | $333 | $7 |
| Pravastatin | 17 | $255 | $15 |
| Simvastatin | 23 | $222 | $10 |
| Warfarin | 14 | $215 | $15 |
| Isosorbide Mononitrate Er | 14 | $197 | $14 |
| Clonidine | 11 | $57 | $5 |
| Cephalexin | 14 | $38 | $3 |
Year by year
| 2024 | 2,476 | 392 | None | 17% | $572,005 |
| 2023 | 2,440 | 396 | None | 18% | $540,742 |
| 2022 | 2,436 | 360 | None | 16% | $415,894 |
| 2021 | 2,216 | 315 | None | 16% | $353,721 |
| 2020 | 2,269 | 306 | None | None | $365,581 |
| 2019 | 2,341 | 309 | None | None | $333,768 |
| 2018 | 2,200 | 285 | None | None | $319,362 |
| 2017 | 2,231 | 291 | None | 28% | $307,838 |
| 2016 | 2,063 | 270 | None | 27% | $246,674 |
| 2015 | 1,876 | 249 | None | 29% | $205,457 |
| 2014 | 1,662 | 237 | 1% (15) | 27% | $152,459 |
| 2013 | 1,710 | 250 | 1% (15) | 28% | $153,339 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Eliquis | 267 | $335,751 | $1,257 |
| Xarelto | 49 | $64,121 | $1,309 |
| Brilinta | 52 | $43,679 | $840 |
| Entresto | 16 | $15,819 | $989 |
| Metoprolol | 290 | $8,173 | $28 |
| Atorvastatin | 262 | $5,158 | $20 |
| Clopidogrel | 196 | $3,951 | $20 |
| Rosuvastatin | 87 | $3,796 | $44 |
| Amlodipine Besylate | 197 | $2,949 | $15 |
| Losartan | 156 | $2,775 | $18 |
| Nebivolol | 20 | $2,230 | $112 |
| Metoprolol | 133 | $2,107 | $16 |
| Ranolazine Er | 14 | $1,801 | $129 |
| Sotalol | 34 | $1,538 | $45 |
| Losartan-Hydrochlorothiazide | 58 | $1,512 | $26 |
| Flecainide Acetate | 12 | $1,276 | $106 |
| Hydralazine | 41 | $1,057 | $26 |
| Pantoprazole | 38 | $916 | $24 |
| Carvedilol | 57 | $898 | $16 |
| Diltiazem 24hr Er (Cd) | 11 | $658 | $60 |
| Simvastatin | 31 | $533 | $17 |
| Pravastatin | 16 | $511 | $32 |
| Isosorbide Mononitrate Er | 17 | $471 | $28 |
| Furosemide | 75 | $466 | $6 |
| Lisinopril | 38 | $371 | $10 |
| Spironolactone | 16 | $370 | $23 |
| Warfarin | 15 | $294 | $20 |
| Omeprazole | 22 | $268 | $12 |
| Famotidine | 12 | $170 | $14 |
2022: 31 drugs
| Eliquis | 220 | $231,250 | $1,051 |
| Xarelto | 49 | $62,885 | $1,283 |
| Brilinta | 69 | $61,140 | $886 |
| Metoprolol | 247 | $6,421 | $26 |
| Atorvastatin | 268 | $4,090 | $15 |
| Clopidogrel | 208 | $3,676 | $18 |
| Losartan | 203 | $3,006 | $15 |
| Rosuvastatin | 62 | $2,706 | $44 |
| Amiodarone | 12 | $2,417 | $201 |
| Amlodipine Besylate | 220 | $2,370 | $11 |
| Nebivolol | 28 | $1,897 | $68 |
| Losartan-Hydrochlorothiazide | 51 | $1,511 | $30 |
| Metoprolol | 132 | $1,394 | $11 |
| Flecainide Acetate | 14 | $1,235 | $88 |
| Carvedilol | 63 | $847 | $13 |
| Pantoprazole | 44 | $833 | $19 |
| Diltiazem 24hr Er (Xr) | 11 | $793 | $72 |
| Hydralazine | 38 | $709 | $19 |
| Ranolazine Er | 13 | $703 | $54 |
| Sotalol | 21 | $696 | $33 |
| Digoxin | 17 | $690 | $41 |
| Lisinopril | 37 | $493 | $13 |
| Warfarin | 30 | $446 | $15 |
| Isosorbide Mononitrate Er | 14 | $438 | $31 |
| Pravastatin | 17 | $419 | $25 |
| Furosemide | 76 | $411 | $5 |
| Simvastatin | 34 | $312 | $9 |
| Spironolactone | 16 | $286 | $18 |
| Minoxidil | 12 | $195 | $16 |
| Omeprazole | 24 | $170 | $7 |
| Cephalexin | 11 | $51 | $5 |
2021: 30 drugs
| Eliquis | 149 | $168,247 | $1,129 |
| Xarelto | 46 | $61,079 | $1,328 |
| Brilinta | 51 | $49,302 | $967 |
| Bystolic | 32 | $13,935 | $435 |
| Metoprolol | 246 | $6,245 | $25 |
| Atorvastatin | 259 | $4,120 | $16 |
| Rosuvastatin | 65 | $3,984 | $61 |
| Losartan | 196 | $3,138 | $16 |
| Edarbi | 12 | $2,595 | $216 |
| Amlodipine Besylate | 181 | $2,006 | $11 |
| Clopidogrel | 148 | $1,977 | $13 |
| Amiodarone | 11 | $1,677 | $152 |
| Metoprolol | 127 | $1,357 | $11 |
| Digoxin | 18 | $1,029 | $57 |
| Diltiazem 24hr Er (Cd) | 19 | $1,013 | $53 |
| Carvedilol | 60 | $905 | $15 |
| Losartan-Hydrochlorothiazide | 27 | $730 | $27 |
| Flecainide Acetate | 12 | $677 | $56 |
| Pravastatin | 26 | $618 | $24 |
| Lisinopril | 45 | $610 | $14 |
| Isosorbide Mononitrate Er | 19 | $533 | $28 |
| Pantoprazole | 17 | $465 | $27 |
| Omeprazole | 31 | $454 | $15 |
| Hydralazine | 30 | $431 | $14 |
| Furosemide | 82 | $419 | $5 |
| Warfarin | 30 | $372 | $12 |
| Simvastatin | 46 | $352 | $8 |
| Spironolactone | 20 | $217 | $11 |
| Lovastatin | 18 | $121 | $7 |
| Atenolol | 12 | $72 | $6 |
2020: 31 drugs
| Eliquis | 184 | $190,162 | $1,033 |
| Xarelto | 39 | $39,337 | $1,009 |
| Brilinta | 48 | $38,068 | $793 |
| Bystolic | 46 | $16,202 | $352 |
| Metoprolol | 226 | $5,428 | $24 |
| Edarbi | 11 | $4,847 | $441 |
| Rosuvastatin | 70 | $4,657 | $67 |
| Atorvastatin | 262 | $3,624 | $14 |
| Losartan | 156 | $2,181 | $14 |
| Clopidogrel | 157 | $2,032 | $13 |
| Losartan-Hydrochlorothiazide | 25 | $1,923 | $77 |
| Amlodipine Besylate | 207 | $1,616 | $8 |
| Metoprolol | 128 | $973 | $8 |
| Diltiazem 24hr Er (Cd) | 21 | $910 | $43 |
| Flecainide Acetate | 11 | $744 | $68 |
| Carvedilol | 61 | $732 | $12 |
| Amiodarone | 11 | $715 | $65 |
| Digoxin | 13 | $682 | $52 |
| Pravastatin | 27 | $616 | $23 |
| Furosemide | 93 | $522 | $6 |
| Hydralazine | 31 | $509 | $16 |
| Valsartan-Hydrochlorothiazide | 11 | $505 | $46 |
| Omeprazole | 39 | $382 | $10 |
| Lisinopril | 50 | $343 | $7 |
| Warfarin | 22 | $296 | $13 |
| Simvastatin | 45 | $270 | $6 |
| Isosorbide Mononitrate Er | 13 | $259 | $20 |
| Spironolactone | 19 | $222 | $12 |
| Pantoprazole | 15 | $166 | $11 |
| Hydrochlorothiazide | 17 | $95 | $6 |
| Famotidine | 12 | $82 | $7 |
2019: 30 drugs
| Eliquis | 201 | $156,663 | $779 |
| Brilinta | 65 | $44,286 | $681 |
| Xarelto | 32 | $36,234 | $1,132 |
| Bystolic | 46 | $15,050 | $327 |
| Metoprolol | 214 | $7,515 | $35 |
| Atorvastatin | 245 | $4,365 | $18 |
| Rosuvastatin | 68 | $4,293 | $63 |
| Amiodarone | 26 | $3,525 | $136 |
| Clopidogrel | 175 | $2,775 | $16 |
| Losartan | 162 | $1,787 | $11 |
| Amlodipine Besylate | 165 | $1,502 | $9 |
| Carvedilol | 70 | $1,275 | $18 |
| Metoprolol | 114 | $883 | $8 |
| Furosemide | 94 | $741 | $8 |
| Propafenone | 13 | $722 | $56 |
| Diltiazem 24hr Er (Cd) | 18 | $706 | $39 |
| Valsartan | 19 | $702 | $37 |
| Isosorbide Mononitrate Er | 25 | $633 | $25 |
| Hydralazine | 28 | $632 | $23 |
| Losartan-Hydrochlorothiazide | 36 | $609 | $17 |
| Pravastatin | 31 | $580 | $19 |
| Olmesartan Medoxomil | 13 | $567 | $44 |
| Lisinopril | 48 | $487 | $10 |
| Omeprazole | 37 | $382 | $10 |
| Pantoprazole | 25 | $376 | $15 |
| Simvastatin | 55 | $315 | $6 |
| Warfarin | 24 | $297 | $12 |
| Spironolactone | 23 | $247 | $11 |
| Hydrochlorothiazide | 20 | $164 | $8 |
| Famotidine | 13 | $102 | $8 |
2018: 33 drugs
| Eliquis | 198 | $136,537 | $690 |
| Brilinta | 66 | $55,191 | $836 |
| Xarelto | 32 | $34,444 | $1,076 |
| Ranexa | 21 | $20,097 | $957 |
| Bystolic | 47 | $13,328 | $284 |
| Metoprolol | 184 | $7,599 | $41 |
| Atorvastatin | 214 | $4,837 | $23 |
| Amiodarone | 22 | $3,790 | $172 |
| Rosuvastatin | 50 | $2,923 | $58 |
| Clopidogrel | 158 | $2,612 | $17 |
| Losartan | 178 | $2,059 | $12 |
| Amlodipine Besylate | 137 | $1,317 | $10 |
| Digox | 13 | $1,253 | $96 |
| Valsartan | 27 | $1,051 | $39 |
| Nitroglycerin | 20 | $983 | $49 |
| Metoprolol | 90 | $899 | $10 |
| Carvedilol | 66 | $751 | $11 |
| Omeprazole | 47 | $729 | $16 |
| Cartia Xt | 16 | $646 | $40 |
| Pravastatin | 29 | $626 | $22 |
| Losartan-Hydrochlorothiazide | 42 | $612 | $15 |
| Pantoprazole | 31 | $531 | $17 |
| Sotalol | 20 | $505 | $25 |
| Spironolactone | 34 | $481 | $14 |
| Lisinopril | 47 | $480 | $10 |
| Diltiazem 24hr Er (Cd) | 12 | $479 | $40 |
| Hydralazine | 29 | $475 | $16 |
| Simvastatin | 54 | $465 | $9 |
| Furosemide | 84 | $458 | $5 |
| Isosorbide Mononitrate Er | 22 | $392 | $18 |
| Warfarin | 17 | $254 | $15 |
| Hydrochlorothiazide | 27 | $116 | $4 |
| Cephalexin | 14 | $64 | $5 |
2017: 38 drugs
| Eliquis | 227 | $116,810 | $515 |
| Brilinta | 83 | $63,861 | $769 |
| Xarelto | 40 | $29,355 | $734 |
| Ranexa | 20 | $15,746 | $787 |
| Bystolic | 44 | $12,866 | $292 |
| Effient | 16 | $11,085 | $693 |
| Metoprolol | 171 | $6,397 | $37 |
| Atorvastatin | 188 | $3,605 | $19 |
| Valsartan | 30 | $3,177 | $106 |
| Rosuvastatin | 38 | $2,338 | $62 |
| Clopidogrel | 136 | $2,140 | $16 |
| Losartan | 173 | $1,498 | $9 |
| Amiodarone | 24 | $1,353 | $56 |
| Digox | 18 | $1,305 | $73 |
| Digoxin | 22 | $1,247 | $57 |
| Cartia Xt | 29 | $1,169 | $40 |
| Nitroglycerin | 15 | $1,053 | $70 |
| Amlodipine Besylate | 118 | $1,023 | $9 |
| Carvedilol | 78 | $726 | $9 |
| Metoprolol | 96 | $644 | $7 |
| Valsartan-Hydrochlorothiazide | 16 | $639 | $40 |
| Simvastatin | 58 | $571 | $10 |
| Losartan-Hydrochlorothiazide | 31 | $556 | $18 |
| Lisinopril | 58 | $498 | $9 |
| Hydralazine | 31 | $495 | $16 |
| Warfarin | 23 | $487 | $21 |
| Spironolactone | 45 | $476 | $11 |
| Omeprazole | 37 | $475 | $13 |
| Furosemide | 95 | $468 | $5 |
| Diltiazem 24hr Er | 13 | $456 | $35 |
| Pravastatin | 15 | $345 | $23 |
| Pantoprazole | 19 | $193 | $10 |
| Famotidine | 17 | $183 | $11 |
| Isosorbide Mononitrate Er | 11 | $157 | $14 |
| Atenolol | 15 | $153 | $10 |
| Lovastatin | 12 | $130 | $11 |
| Hydrochlorothiazide | 19 | $97 | $5 |
| Cephalexin | 13 | $54 | $4 |
2016: 36 drugs
| Eliquis | 158 | $65,817 | $417 |
| Xarelto | 72 | $41,203 | $572 |
| Brilinta | 68 | $34,542 | $508 |
| Effient | 14 | $12,806 | $915 |
| Ranexa | 14 | $10,076 | $720 |
| Crestor | 14 | $8,342 | $596 |
| Metoprolol | 191 | $8,132 | $43 |
| Bystolic | 24 | $5,473 | $228 |
| Atorvastatin | 133 | $3,295 | $25 |
| Tribenzor | 12 | $3,171 | $264 |
| Valsartan | 44 | $2,966 | $67 |
| Cartia Xt | 39 | $2,334 | $60 |
| Clopidogrel | 126 | $2,292 | $18 |
| Digox | 33 | $1,772 | $54 |
| Losartan | 149 | $1,636 | $11 |
| Amlodipine Besylate | 118 | $1,117 | $9 |
| Amiodarone | 20 | $1,098 | $55 |
| Valsartan-Hydrochlorothiazide | 19 | $911 | $48 |
| Warfarin | 55 | $818 | $15 |
| Carvedilol | 72 | $750 | $10 |
| Losartan-Hydrochlorothiazide | 34 | $647 | $19 |
| Digoxin | 11 | $581 | $53 |
| Isosorbide Mononitrate Er | 23 | $573 | $25 |
| Simvastatin | 52 | $537 | $10 |
| Lisinopril | 43 | $528 | $12 |
| Furosemide | 78 | $478 | $6 |
| Metoprolol | 66 | $466 | $7 |
| Hydralazine | 17 | $428 | $25 |
| Omeprazole | 29 | $343 | $12 |
| Diltiazem 24hr Er | 11 | $313 | $28 |
| Spironolactone | 19 | $230 | $12 |
| Atenolol | 17 | $206 | $12 |
| Pantoprazole | 23 | $187 | $8 |
| Metformin | 13 | $133 | $10 |
| Famotidine | 16 | $115 | $7 |
| Hydrochlorothiazide | 18 | $69 | $4 |
2015: 36 drugs
| Xarelto | 106 | $54,731 | $516 |
| Eliquis | 85 | $31,104 | $366 |
| Brilinta | 71 | $26,416 | $372 |
| Effient | 13 | $10,958 | $843 |
| Bystolic | 32 | $8,523 | $266 |
| Crestor | 15 | $8,058 | $537 |
| Metoprolol | 180 | $7,316 | $41 |
| Ranexa | 13 | $6,598 | $508 |
| Tribenzor | 17 | $6,006 | $353 |
| Valsartan | 32 | $3,065 | $96 |
| Cartia Xt | 59 | $2,745 | $47 |
| Atorvastatin | 94 | $2,728 | $29 |
| Clopidogrel | 153 | $2,195 | $14 |
| Digox | 23 | $1,416 | $62 |
| Losartan | 124 | $1,094 | $9 |
| Digoxin | 17 | $1,024 | $60 |
| Amiodarone | 21 | $971 | $46 |
| Isosorbide Mononitrate Er | 41 | $867 | $21 |
| Warfarin | 62 | $864 | $14 |
| Amlodipine Besylate | 111 | $779 | $7 |
| Valsartan-Hydrochlorothiazide | 15 | $715 | $48 |
| Losartan-Hydrochlorothiazide | 29 | $584 | $20 |
| Carvedilol | 74 | $566 | $8 |
| Simvastatin | 39 | $353 | $9 |
| Furosemide | 55 | $334 | $6 |
| Nitrostat | 14 | $328 | $23 |
| Hydralazine | 20 | $316 | $16 |
| Potassium Chloride | 15 | $313 | $21 |
| Lisinopril | 33 | $224 | $7 |
| Omeprazole | 24 | $211 | $9 |
| Pantoprazole | 13 | $183 | $14 |
| Famotidine | 14 | $140 | $10 |
| Metoprolol | 25 | $133 | $5 |
| Atenolol | 18 | $110 | $6 |
| Spironolactone | 13 | $75 | $6 |
| Hydrochlorothiazide | 13 | $61 | $5 |
2014: 35 drugs
| Xarelto | 123 | $48,454 | $394 |
| Effient | 25 | $10,775 | $431 |
| Crestor | 23 | $9,771 | $425 |
| Diovan | 36 | $9,733 | $270 |
| Ranexa | 20 | $7,279 | $364 |
| Metoprolol | 145 | $6,421 | $44 |
| Azor | 13 | $5,590 | $430 |
| Bystolic | 33 | $4,891 | $148 |
| Eliquis | 12 | $3,732 | $311 |
| Clopidogrel | 166 | $3,233 | $19 |
| Brilinta | 12 | $3,220 | $268 |
| Diltiazem 24hr Er | 18 | $2,123 | $118 |
| Atorvastatin | 69 | $1,996 | $29 |
| Digox | 36 | $1,815 | $50 |
| Valsartan-Hydrochlorothiazide | 14 | $1,457 | $104 |
| Cartia Xt | 37 | $1,450 | $39 |
| Isosorbide Mononitrate Er | 58 | $1,162 | $20 |
| Warfarin | 78 | $1,040 | $13 |
| Losartan | 100 | $903 | $9 |
| Digoxin | 14 | $789 | $56 |
| Carvedilol | 64 | $706 | $11 |
| Diltiazem 24hr Cd | 11 | $573 | $52 |
| Hydralazine | 18 | $504 | $28 |
| Amlodipine Besylate | 70 | $449 | $6 |
| Losartan-Hydrochlorothiazide | 19 | $446 | $23 |
| Simvastatin | 37 | $440 | $12 |
| Lisinopril | 42 | $289 | $7 |
| Omeprazole | 34 | $289 | $8 |
| Amiodarone | 14 | $263 | $19 |
| Furosemide | 47 | $235 | $5 |
| Metoprolol | 28 | $180 | $6 |
| Spironolactone | 13 | $148 | $11 |
| Famotidine | 12 | $119 | $10 |
| Atenolol | 15 | $69 | $5 |
| Cephalexin | 12 | $64 | $5 |
2013: 38 drugs
| Xarelto | 136 | $46,056 | $339 |
| Clopidogrel | 154 | $11,326 | $74 |
| Effient | 20 | $8,520 | $426 |
| Pradaxa | 23 | $7,445 | $324 |
| Diovan | 28 | $7,370 | $263 |
| Crestor | 24 | $7,001 | $292 |
| Metoprolol | 134 | $6,610 | $49 |
| Ranexa | 12 | $4,669 | $389 |
| Azor | 11 | $4,137 | $376 |
| Valsartan-Hydrochlorothiazide | 13 | $3,835 | $295 |
| Bystolic | 26 | $3,132 | $120 |
| Diltiazem 24hr Er | 20 | $1,431 | $72 |
| Atorvastatin | 38 | $1,429 | $38 |
| Cartia Xt | 27 | $1,404 | $52 |
| Warfarin | 83 | $1,257 | $15 |
| Losartan | 78 | $1,140 | $15 |
| Isosorbide Mononitrate Er | 33 | $890 | $27 |
| Carvedilol | 76 | $887 | $12 |
| Diltiazem 24hr Cd | 31 | $865 | $28 |
| Simvastatin | 69 | $809 | $12 |
| Hydralazine | 19 | $749 | $39 |
| Amlodipine Besylate | 52 | $602 | $12 |
| Propafenone | 13 | $577 | $44 |
| Labetalol | 13 | $533 | $41 |
| Omeprazole | 41 | $455 | $11 |
| Lisinopril | 47 | $406 | $9 |
| Pantoprazole | 25 | $402 | $16 |
| Sotalol | 21 | $363 | $17 |
| Nitrostat | 12 | $240 | $20 |
| Famotidine | 12 | $201 | $17 |
| Metoprolol | 40 | $200 | $5 |
| Levofloxacin | 16 | $189 | $12 |
| Amiodarone | 12 | $189 | $16 |
| Furosemide | 41 | $171 | $4 |
| Hydrochlorothiazide | 34 | $161 | $5 |
| Digox | 14 | $134 | $10 |
| Spironolactone | 11 | $110 | $10 |
| Atenolol | 13 | $78 | $6 |
Money from drug and device companies
$376 in 2025
| 2025 | 10 | 17 | None | $376 |
| 2024 | 13 | 23 | None | $594 |
| 2023 | 11 | 22 | None | $463 |
| 2022 | 9 | 23 | None | $889 |
| 2021 | 7 | 11 | None | $348 |
| 2020 | 4 | 6 | None | $162 |
| 2019 | 9 | 49 | None | $592 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Eliquis | $118 | 5 payments
|
| Novartis Pharmaceuticals | Leqvio | $54 | 2 payments
|
| Amgen | Repatha | $37 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $32 | 2 payments
|
| Heartflow | Ffrct | $27 | 1 payment
|
| Pfizer | Eliquis | $25 | 1 payment
|
See all 17 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Eliquis | $19 |
| Heartflow | Meals · 2025-10-16 | Ffrct | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-06 | Eliquis | $31 |
| Abbott Laboratories | Meals · 2025-09-23 | Cardiomems | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-04 | Eliquis | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-07 | Eliquis | $19 |
| Amgen | Meals · 2025-07-24 | Repatha | $20 |
| Baxter Healthcare | Meals · 2025-06-12 | Hillrom - Carnation Ambulatory Monitor | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-05 | Eliquis | $34 |
| Novo Nordisk | Meals · 2025-05-29 | Wegovy | $21 |
| Boston Scientific | Meals · 2025-05-01 | Watchman Flx | $18 |
| Pfizer | Meals · 2025-04-16 | Eliquis | $25 |
| Amgen | Meals · 2025-04-03 | Repatha | $17 |
| Baxter Healthcare | Meals · 2025-03-21 | Hillrom - Carnation Ambulatory Monitor | $17 |
| Novartis Pharmaceuticals | Meals · 2025-03-06 | Leqvio | $32 |
| Edwards Lifesciences | Meals · 2025-02-27 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $22 |
| Novartis Pharmaceuticals | Meals · 2025-01-21 | Entresto | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $594
| Novartis Pharmaceuticals | Leqvio | $111 | 4 payments
|
| Penumbra | Penumbra System | $88 | 1 payment
|
| Boston Scientific | Watchman Flx | $61 | 3 payments
|
| Novo Nordisk | Ozempic | $55 | 3 payments
|
| Amgen | Repatha | $52 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $48 | 2 payments
|
| Pfizer | Eliquis | $47 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $26 | 1 payment
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $26 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $26 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $20 | 1 payment
|
| Abbott Laboratories | Amplatzer Amulet | $18 | 1 payment
|
| Biotronik | Acticor 7 Vr-T Dx | $15 | 1 payment
|
2023: $463
| Pfizer | Eliquis | $86 | 4 payments
|
| Merck Sharp & Dohme | Verquvo | $78 | 4 payments
|
| Boston Scientific | Watchman Flx | $58 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $57 | 3 payments
|
| Novo Nordisk | Rybelsus | $39 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $35 | 1 payment
|
| Amgen | Repatha | $25 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $24 | 1 payment
|
| Abbott Laboratories | Mitraclip | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
2022: $889
| Medtronic | Micra | $410 | 5 payments
|
| Abiomed | Impella | $147 | 1 payment
|
| Boston Scientific | Watchman Access System | $83 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $81 | 5 payments
|
| Merck Sharp & Dohme | Verquvo | $57 | 3 payments
|
| Novo Nordisk | Rybelsus | $31 | 2 payments
|
| Abbott Laboratories | Xience Sierra | $28 | 1 payment
|
| Pfizer | Eliquis | $27 | 2 payments
|
| Philips Electronics North America | (5027) Intact Vascular Und | $24 | 1 payment
|
2021: $348
| AstraZeneca Pharmaceuticals LP | Brilinta | $99 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $61 | 2 payments
|
| Medtronic | Micra | $53 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $53 | 3 payments
|
| Amgen | Repatha | $52 | 2 payments
|
| Pfizer | Eliquis | $16 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $14 | 1 payment
|
2020: $162
| Bardy Diagnostics | Carnation Ambulatory Monitor | $82 | 2 payments
|
| Medtronic Vascular | Micra | $37 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $22 | 1 payment
|
| Abbott Laboratories | Mitra Clip System | $20 | 1 payment
|
2019: $592
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $269 | 38 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $106 | 1 payment
|
| Boston Scientific | General - Atherectomy | $55 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $52 | 3 payments
|
| Regeneron Pharmaceuticals | None | $33 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $32 | 2 payments
|
| Abbott Laboratories | Confirm Rx | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $15 | 1 payment
|
| Pfizer | Eliquis | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1922005636
- Licence
- CA 00G844650
- Trained
- University of Colorado School of Medicine, Denver, 1991
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 200 Jose Figueres Ave, Ste 320, San Jose, CA, 95116
- NPI first listed
- 2005-07-07
- NPI last updated
- 2013-08-26
This is when the NPI record was last certified, not a medical board exam.